| iShares U.S. Pharmaceuticals ETF | ― | | ― | 132.41K | ― | Moderate Buy | | 0.38% | $1.30B | | |
| VanEck Pharmaceutical ETF | ― | | ― | 240.12K | ― | Moderate Buy | | 0.36% | $958.87M | | |
| SPDR S&P Pharmaceuticals ETF | ― | | ― | 72.28K | ― | Moderate Buy | | 0.35% | $447.12M | | |
| Invesco Dynamic Pharmaceuticals ETF | ― | | ― | 25.54K | ― | Moderate Buy | | 0.57% | $367.99M | | |
| Defiance Daily Target 2X Long LLY ETF | ― | | ― | 596.08K | ― | ― | | 1.32% | $67.61M | | ― |
| Defiance Daily Target 2X Long NVO ETF | ― | | ― | 661.10K | ― | ― | | 1.30% | $50.18M | | ― |
| First Trust Nasdaq Pharmaceuticals ETF | ― | | ― | 9.07K | ― | Moderate Buy | | 0.60% | $37.41M | | |
| Direxion Daily LLY Bull 2X Shares | ― | | ― | 119.45K | ― | ― | | 1.07% | $23.08M | | ― |
| Novo Nordisk A/S (B Shares) ADRhedged | ― | | ― | 2.52K | ― | Moderate Sell | | 0.19% | $4.26M | | |
| GSK plc ADRhedged | ― | | ― | 625.00 | ― | Moderate Buy | | 0.19% | $733.26K | | |
